19.92
+0.23(+1.17%)
Currency In USD
| Previous Close | 19.69 |
| Open | 19.72 |
| Day High | 20.18 |
| Day Low | 19.63 |
| 52-Week High | 23.64 |
| 52-Week Low | 3.6 |
| Volume | 2.49M |
| Average Volume | 5.18M |
| Market Cap | 4.71B |
| PE | 73.78 |
| EPS | 0.27 |
| Moving Average 50 Days | 19.04 |
| Moving Average 200 Days | 12.65 |
| Change | 0.23 |
If you invested $1000 in ADMA Biologics, Inc. (ADMA) 10 years ago, it would be worth $1,844.44 as of December 04, 2024 at a share price of $19.92. Whereas If you bought $1000 worth of ADMA Biologics, Inc. (ADMA) shares 5 years ago, it would be worth $4,709.22 as of December 04, 2024 at a share price of $19.92.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
ADMA Biologics Announces Third Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire Inc.
Nov 07, 2024 9:05 PM GMT
3Q 2024 Total Revenue of $119.8 Million, a 78% Increase Y-o-Y 3Q 2024 GAAP Net Income of $35.9 Million, a 1,300% Increase Y-o-Y 3Q 2024 Adjusted EBITDA(1) of $45.4 Million, a 256% Increase Y-o-Y KPMG LLP Engaged as New Independent Registered Publi
ADMA Biologics to Report Third Quarter 2024 Financial Results on November 7, 2024
GlobeNewswire Inc.
Oct 29, 2024 8:10 PM GMT
Conference Call Scheduled for November 7, 2024, at 4:30 p.m. ETRAMSEY, N.J. and BOCA RATON, Fla., Oct. 29, 2024 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (Nasdaq: ADMA) (“ADMA” or the “Company”), an end-to-end commercial biopharmaceutical company de
ADMA Biologics Set to Join S&P SmallCap 600 Index
GlobeNewswire Inc.
Sep 17, 2024 11:00 AM GMT
RAMSEY, N.J. and BOCA RATON, Fla., Sept. 17, 2024 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (Nasdaq: ADMA) (“ADMA”), an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing, and developing specialty biologics, today